All Updates

CHARLESTON, W. Va. – The American Cancer Society Cancer Action Network is marking the American Cancer Society’s 45th annual Great American Smokeout happening today by calling on state lawmakers to protect the health of our youth, residents with lower incomes, LGBTQ+ communities and communities of color by passing strong tobacco

COLUMBUS, OHIO – The American Cancer Society Cancer Action Network (ACS CAN) is marking the American Cancer Society’s 45th annual Great American Smokeout happening today by calling on state lawmakers to protect the health of our youth, low-income Ohioans, LGBTQ+ communities and communities of color by passing strong tobacco

Louisville, KY – Cancer patients and survivors are marking the American Cancer Society’s (ACS) 45th annual Great American Smokeout today by calling on state lawmakers to protect the health of Kentucky residents by passing strong tobacco control legislation. As our battle with COVID-19 continues, we must do everything in our

TALLAHASSEE, FL – November 19, 2020 – Cancer patients and survivors are marking the American Cancer Society’s (ACS) 45 th annual Great American Smokeout today by calling attention to the state-funded adult and youth tobacco control prevention programs that have helped them quit and protected the health of Floridians

CHEYENNE, Wyo – Cancer patients and survivors mark the American Cancer Society’s (ACS) 45 th annual Great American Smokeout today by calling on lawmakers to protect the health of Wyoming residents by prioritizing strong tobacco control policies, including the state’s tobacco prevention and cessation program. As our battle with COVID-19

As millions of seniors and other enrollees select their 2021 Medicare health benefits during annual open enrollment, a new report details just how confusing the program’s appeals process can be should a patient need to appeal a claim denial for health care services or prescription drugs.

According to an article published this week in JAMA Oncology , nearly 1 in 5 cancer patients surveyed said the pandemic would make them less likely to enroll in a trial. The top reason given for not enrolling is fear of COVID-19 exposure.